The Future of Artificial Intelligence Applied to Perioperative Immunotherapy Trials: Renal Cell Carcinoma

2022 ◽  
pp. 299-302
Author(s):  
Alberto Martini ◽  
Alessandro Larcher
Keyword(s):  
Artificial Intelligence ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
The Future

scholarly journals The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?

2019 ◽  
Vol 15 (15) ◽  
pp. 1683-1695 ◽  
Author(s):  
Hiten D Patel ◽  
Maneka Puligandla ◽  
Brian M Shuch ◽  
Bradley C Leibovich ◽  
Anil Kapoor ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Perioperative Therapy ◽  
The Future

scholarly journals From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma

Cells ◽  
2021 ◽  
Vol 10 (11) ◽  
pp. 3231
Author(s):  
Jonathan Anker ◽  
Justin Miller ◽  
Nicole Taylor ◽  
Natasha Kyprianou ◽  
Che-Kai Tsao
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Tumor Immunology ◽  
Checkpoint Inhibitors ◽  
Direct Result ◽  
Secondary Resistance ◽  
Improved Outcomes ◽  
The Future ◽  
Cancer Types

Immunotherapy has revolutionized the treatment landscape for many cancer types. The treatment for renal cell carcinoma (RCC) has especially evolved in recent years, from cytokine-based immunotherapies to immune checkpoint inhibitors. Although clinical benefit from immunotherapy is limited to a subset of patients, many combination-based approaches have led to improved outcomes. The success of such approaches is a direct result of the tumor immunology knowledge accrued regarding the RCC microenvironment, which, while highly immunogenic, demonstrates many unique characteristics. Ongoing translational work has elucidated some of the mechanisms of response, as well as primary and secondary resistance, to immunotherapy. Here, we provide a comprehensive review of the RCC immunophenotype with a specific focus on how preclinical and clinical data are shaping the future of immunotherapy.

RENAL CELL CARCINOMA: WHAT DOES THE FUTURE HOLD?

2008 ◽  
Vol 102 (1) ◽  
pp. 5-6 ◽  
Author(s):  
Thomas E. Hutson
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
The Future

Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma

2005 ◽  
Vol 96 (3) ◽  
pp. 281-285 ◽  
Author(s):  
John T. Leppert ◽  
John S. Lam ◽  
Allan J. Pantuck ◽  
Robert A. Figlin ◽  
Arie S. Belldegrun
Keyword(s):  
Renal Cell Carcinoma ◽  
Molecular Markers ◽  
Carbonic Anhydrase ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Carbonic Anhydrase Ix ◽  
The Future

Combination therapy in metastatic renal cell carcinoma: Back to the future?

2020 ◽  
Vol 47 (6) ◽  
pp. 361-366
Author(s):  
Luigi Cerbone ◽  
Carlo Cattrini ◽  
Giacomo Vallome ◽  
Maria Maddalena Latocca ◽  
Francesco Boccardo ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Combination Therapy ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
The Future

The future of adjuvant therapy for renal cell carcinoma

2012 ◽  
Vol 9 (4) ◽  
pp. 451-462 ◽  
Author(s):  
Sarah J Welsh ◽  
Tobias Janowitz ◽  
Tim Eisen
Keyword(s):  
Renal Cell Carcinoma ◽  
Adjuvant Therapy ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
The Future
Sign in / Sign up

Export Citation Format

Share Document